P-One Clinic

Hachiōji 192-0071

2 studies enrolling now · 6 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Dementia, Healthy, Hypertension, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Obesity, Parkinson Disease, Plaque, Amyloid

Studies at this site

• A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). — Recruiting now
• A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Recruiting now
• A Study of LY3971297 in Healthy Participants — Running, not enrolling
• A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Completed
• A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3) — Running, not enrolling
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling